AzTrials
AzTrials

ADHDNCT02942030

Differences in Attentional Profile of Children Diagnosed With ADHD Versus Children Diagnosed With Other Mental Conditions

An observational study of ADHD, run by Clalit Health Services at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Attentional symptoms characterize both ADHD and other mental conditions in children. The diagnosis is based on clinical psychiatric evaluation. With the expanding knowledge regarding the neurobiological basis in ADHD the investigators have learned that attention is not a general property of the whole brain, but… Read more about this study

Who is it for?
Ages 8 to 12 years
Conditions the study is for
ADHD
What is being tested?
Computerized assesment battery
How many people
70 participants
Where
1 siteIsrael
Study dates
Nov 2016to Nov 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: 8-12 y/o children reffered to a psychiatric clinic for evaluation

Who may be able to join

  • age 8-12
  • normal intelligence quotient (IQ)
  • suspected ADHD

Who cannot join

  • Autism Spectrum Disorder
  • blindness
  • deafness
  • abnormal intelligence quotient (IQ) (below 70)

Trial locations and contacts

1 site in 1 country.

shlomit tsafrir, MD contact

972-2-5663638

stsafrir@clalit.org.il

Israel1 site
  • Mishmar Ha'Am Clinic

    Jerusalem

    shlomit tsafrir, md, 972-25663638, stsafrir@clalit.org.il

Other trials in Israel

About this study

Attentional symptoms characterize both ADHD and other mental conditions in children.

The diagnosis is based on clinical psychiatric evaluation.

Read more

With the expanding knowledge regarding the neurobiological basis in ADHD the investigators have learned that attention is not a general property of the whole brain, but involves several coordinated networks. This knowledge promoted the scientific community to the stage in which scientists can recognize different types of attention domains.

in the current study, the investigators use computerized battery to separate between the different attention abilities and provide specific attentional profile. in this study the investigators aim to characterize different attentional profiles in children who are diagnosed with ADHD versus children who diagnosed with other mental condition (which are common differential diagnoses of ADHD)

Read the detailed description

Attentional symptoms characterize both ADHD and other mental conditions in children.

The diagnosis of ADHD is based on clinical psychiatric evaluation in different clinical situations the differential diagnosis is not straight forward and the clinician considers a common co-morbid conditions and common differential diagnoses.

With the expanding knowledge regarding the neurobiological basis in ADHD the scientific community have learned that attention is not a general property of the whole brain, but involves several coordinated networks. This knowledge promoted us to the stage in which scientists can recognize different types of attention domains. this knowledge raises the question - can the clinician use this knowledge to make the correct diagnosis based on specific attentional profile?

In the current study, the investigators use computerized battery in order to separate between the different attention abilities and provide specific attentional profile. in this study the investigators aim to characterize different attentional profiles in children who are diagnosed with ADHD versus children who diagnosed with other mental condition (which are common differential diagnoses of ADHD)

Conditions
ADHD
Being tested
Computerized assesment battery
Medical subject headings
Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Computerized assesment batteryOther

    All participants will do a computerized assessment battery to identify specific attentional profile

Study groups in NCT02942030
Study groupRoleWhat they receive
ADHDChildren diagnosed with ADHD after a complete psychiatric evaluation.
Receives: Other: Computerized assesment battery
Non-ADHDChildren diagnosed with other mental conditions after a complete psychiatric evaluation.
Receives: Other: Computerized assesment battery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. diagnosis - after psychiatric evaluation

    Measured: november 2017

  2. attentional computerized profile

    Measured: november 2017

Secondary outcomes (1)
  1. correlations - clinical diagnosis and attentional profile

    Measured: november 2017

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2016 (estimated)
  2. Study startNov 2016
  3. Primary completionNov 2017 (estimated)
  4. Study completionNov 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02942030
Sponsor's protocol ID
000816-com2
Status last verified
Oct 2016
First submitted
20 Oct 2016
Last updated
29 Nov 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of ADHD, run by Clalit Health Services at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact shlomit tsafrir, MD (972-2-5663638, stsafrir@clalit.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

diagnosis - after psychiatric evaluation (time frame: november 2017). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in